COVID – 19 | Vaccination Update – Day 597

ad
Single-shot COVID-19 vaccine protects non-human primates
Single-shot COVID-19 vaccine protects non-human primates

India’s COVID-19 vaccination coverage has crossed 213.50 Crore (2,13,50,71,266today. More than 29 lakh (29,34,042) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10414279
2nd Dose 10108740
Precaution Dose 6807328
FLWs 1st Dose 18435003
2nd Dose 17702469
Precaution Dose 13245023
Age Group 12-14 years 1st Dose 40464130
2nd Dose 30476336
Age Group 15-18 years 1st Dose 61728933
2nd Dose 52474373
Age Group 18-44 years 1st Dose 560722413
2nd Dose 513651691
Precaution Dose 68401822
Age Group 45-59 years 1st Dose 203931265
2nd Dose 196457043
Precaution Dose 37594395
Over 60 years 1st Dose 127599547
2nd Dose 122800282
Precaution Dose 42056194
Cumulative 1st dose administered 1023295570
Cumulative 2nd dose administered 943670934
Precaution Dose 168104762
Total 2135071266

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 04th September, 2022 (597th Day)
HCWs 1st Dose 59
2nd Dose 1293
Precaution Dose 15552
FLWs 1st Dose 124
2nd Dose 1888
Precaution Dose 25176
Age Group 12-14 years 1st Dose 8123
2nd Dose 25260
Age Group 15-18 years 1st Dose 3297
2nd Dose 12806
Age Group 18-44 years 1st Dose 37835
2nd Dose 177220
Precaution Dose 1543562
Age Group 45-59 years 1st Dose 9660
2nd Dose 56653
Precaution Dose 635571
Over 60 years 1st Dose 5651
2nd Dose 35617
Precaution Dose 338695
Cumulative 1st dose administered 64749
Cumulative 2nd dose administered 310737
Precaution Dose 2558556
Total 2934042

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply